In particular, both Crk and CrkL have been demonstrated to be important for tumor cell migration and invasion in colorectal cancer, glioblastoma, ovarian cancer, cervical cancer, gastric cancer, and hepatocellular carcinoma (Figure 1). This evidence concerns the gene CRKL and hepatocellular carcinoma.